The top-performing pharma and biotech stocks as group sees resurgence
Source: SeekingAlpha
2026-02-13 14:01:58 ET
More on pharmaceuticals, biotech
- Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
- BBH: Mature Biotech Exposure, But Limited Growth Ahead
- XPH: Healthcare Dashboard For January
- Most and least shorted mid-to mega-cap healthcare stocks in January
- FDA opens fast-track program to speed U.S. drug plant construction
Read the full article on Seeking Alpha
For further details see:
The top-performing pharma and biotech stocks as group sees resurgence
SPDR Series Trust S&P Biotech
NASDAQ: XBI
XBI Trading
2.07% G/L:
$128.40 Last:
5,084,091 Volume:
$126.69 Open:
XBI Latest News
November 17, 2025 09:18:00 pm
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge.
